AI Article Synopsis

  • Many individuals with intellectual disabilities (ID) and psychiatric disorders use regular mental health services in Europe.
  • Only 56% of European countries offer specialized postgraduate training in psychiatry focused on intellectual disabilities.
  • The article discusses the difficulties in training for ID and suggests recommendations for policymakers in education and health to improve the situation.

Article Abstract

The majority of people with intellectual disabilities (ID) and psychiatric disorders access mainstream mental health services across Europe. However, only 56% of countries provide postgraduate psychiatric training in ID according to a survey across 42 European countries. We explore the challenges of ID training and make recommendations for education and health policymakers.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737176PMC
http://dx.doi.org/10.1192/j.eurpsy.2020.102DOI Listing

Publication Analysis

Top Keywords

training psychiatrists
4
psychiatrists develop
4
develop skills
4
skills intellectual
4
intellectual disability
4
disability psychiatry?
4
psychiatry? current
4
current european
4
european context
4
context future
4

Similar Publications

Background: The imposter phenomenon is the unwillingness to acknowledge one's triumphs, which is common among doctors. Research on the imposter phenomenon among mental health professionals is limited, and the relationship between imposter phenomenon, burnout, and compassion fatigue has not been studied. The current study intended to test a hypothesized model of the specific impact paths among burnout, compassion fatigue, maladaptive perfectionism, and imposter phenomenon among mental health professionals.

View Article and Find Full Text PDF

Introduction: Increased aggression in a regional Comprehensive Psychiatric Emergency Program (CPEP) led to a significant rise in physical assaults, restraints, and use of security personnel. Root cause analysis revealed a need for more extensive training on de-escalation, teamwork and communication.

Aims: This quality improvement project evaluated the impact of an interprofessional, high-fidelity simulation project on interdisciplinary collaboration to manage de-escalation and aggression safely and effectively.

View Article and Find Full Text PDF

Background: Predicting dementia early has major implications for clinical management and patient outcomes. Yet, we still lack sensitive tools for stratifying patients early, resulting in patients being undiagnosed or wrongly diagnosed. Despite rapid expansion in machine learning models for dementia prediction, limited model interpretability and generalizability impede translation to the clinic.

View Article and Find Full Text PDF
Article Synopsis
  • Schizophrenia (SZ) is a complex mental disorder that affects various aspects of a person's functioning and is typically diagnosed based on subjective evaluations by psychiatrists, which can lead to biases and inaccuracies.
  • A new model called SchizoLMNet, which uses modified MobileNetV2 architecture, is introduced to diagnose SZ more effectively by analyzing EEG signals transformed into spectrogram images, boasting high accuracy rates in distinguishing between SZ and healthy individuals.
  • This innovative framework seeks to advance into real-time clinical applications using mobile technology, enhancing communication between medical professionals and patients to improve SZ management.
View Article and Find Full Text PDF

Background: Many variables may affect approaches of psychiatrists to methamphetamine-associated psychotic disorder (MAP) treatment. This study was aimed to reach adult psychiatrists actively practicing in Turkey through an internet-based survey and to determine their practices and attitudes to MAP treatment.

Methods: In this internet-based study, participants were divided into three groups based on their answers: Those who do not follow-up any MAP patient were group 1 (n = 78), partially involved in the treatment process of at least one patient diagnosed with MAP were group 2 (n = 128), completely involved in the treatment process of at least one patient diagnosed with MAP were group 3 (n = 202).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!